Zhejiang Huayuan Auto Technology
301535
Zhejiang Huaye Plastics Machinery
301616
SANWEI CO.,LTD.
831834
4
THEC
833509
5
Huarong Chemical
301256
CN Stock MarketDetailed Quotes
300966 Hubei Goto Biopharm
- 16.69
- +0.14+0.85%
Market Closed Mar 27 15:00 CST
1.92BMarket Cap-137.93P/E (TTM)
16.78High16.14Low27.12KlotVolume16.55Open16.55Pre Close44.78MTurnover3.54%Turnover Ratio83.45P/E (Static)115.28MShares23.7852wk High2.29P/B1.28BFloat Cap13.4352wk Low19.86Limit Up76.66MShs Float79.83Historical High13.24Limit Down3.87%Amplitude12.01Historical Low0.02Dividend TTM16.51Avg Price12.97KlotAsk0.10%Div YieldTTM100Lot Size13.50KlotBid
Hubei Goto Biopharm News
Kyodo Pharmaceutical: Announcement on the initial repurchase of the company\'s shares
Kyodo Pharmaceutical: Announcement on progress in the repurchase of the company\'s shares
Kyodo Pharmaceutical: Repurchase Report
Kyodo Pharmaceutical: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Kyodo Pharmaceutical: Announcement on the expiration of the period of the holdings reduction plan for the controlling shareholders and actual controllers and the results of the holdings reduction
Kyodo Pharmaceutical: Pre-disclosure Notice Concerning Reduction of Shareholdings by Controlling Shareholders and Actual Controllers
Hubei Goto Biopharm: Announcement regarding the expiration of the shareholding reduction plan for shareholders and directors holding more than 5% of the shares.
Hubei Goto Biopharm: Announcement of the implementation of equity distribution in 2023.
Hubei Goto Biopharm: Announcement on shareholders and directors holding 5% or more of the company's shares reduced their holdings by 1% and the completion of the supervisors' holdings reduction plan
Hubei Goto Biopharm: Announcement on the abolition of restricted stocks that have been partially granted in the 2023 Restricted Stock Incentive Plan but have not yet been vested
Hubei Goto Biopharm: Announcement on the 2023 Profit Distribution Plan
Hubei Goto Biopharm: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the abolition of some restricted stocks in the 2023 Restricted Stock Incentive Plan of Hubei Kyodo Pharmaceutical Co., Ltd.
Kyodo Pharmaceutical: Pre-disclosure Notice on Reduction of Shareholdings by Shareholders, Directors and Supervisors Holding 5% or More of Their Shares
Kyodo Pharmaceutical: Explanation of the supervisory board's inspection opinions and disclosure on the list of incentive recipients reserved for the company's 2023 restricted stock incentive plan
Kyodo Pharmaceutical: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the 2023 Restricted Stock Incentive Plan Reservation and Grant of Hubei Kyodo Pharmaceutical Co., Ltd.
Kyodo Pharmaceutical: Supervisory Board's review opinion on the list of incentive recipients reserved for the company's 2023 restricted stock incentive plan (as of the grant date)
Kyodo Pharmaceutical: 2023 Restricted Stock Incentive Plan Reserve Award Recipient List (as of grant date)
Kyodo Pharmaceutical: Announcement on reserving and granting restricted shares to incentive recipients
Kyodo Pharmaceutical: Prompt announcement on the commencement of mutual debt conversion to shares
Kyodo Pharmaceutical: Announcement on the company's 2022 profit distribution plan